Mirabilis Raises $4 Million to Commercialize Non-Invasive Treatment of Uterine Fibroids
Mirabilis Medica, Inc., a privately-held medical device company, announced the initial closing of a $4 million Series A financing that will be used to complete development, testing and introduction of its image-guided High Intensity Focused Ultrasound (HIFU) system for treatment of gynecological diseases. The financing was co-led by Charter Life Sciences of Palo Alto and vSpring Capital of Salt Lake City [more...]
|
|
|
